1] Department of Human Science, SNHS, Georgetown University Medical Center, Washington, DC, USA [2] Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
Oncogene. 2013 Oct 17;32(42):5005-16. doi: 10.1038/onc.2012.522. Epub 2012 Dec 17.
The BRCA1 tumor suppressor protein heterodimerizes with its partner protein, BARD1, via the RING domain present in both proteins. The heterodimer contains an E3 ubiquitin ligase activity and participates in multiple cellular functions such as cell cycle control, DNA repair and regulation of gene transcription, collectively aimed at maintaining genomic stability and tumor suppression. Yet, the precise role of BRCA1 E3 ligase in these cellular functions is poorly understood. We present data showing that BRCA1 ubiquitinates G2/M cell cycle proteins, cyclin B and Cdc25C, leading to their accelerated degradation via a mechanism that is independent of APC/C. BRCA1-dependent degradation of cyclin B and Cdc25C is reversed by proteasome inhibitors and is enhanced following DNA damage, which may represent a possible mechanism to prevent cyclin B and Cdc25C accumulation, a requirement for mitotic entry. Our data provide mechanistic insight into how BRCA1 E3 ligase activity regulates the G2/M cell cycle checkpoint and, thus, contributes to maintenance of genomic stability.
BRCA1 肿瘤抑制蛋白通过其伴侣蛋白 BARD1 中的 RING 结构域形成异二聚体。该异二聚体具有 E3 泛素连接酶活性,并参与多种细胞功能,如细胞周期控制、DNA 修复和基因转录调控,共同旨在维持基因组稳定性和肿瘤抑制。然而,BRCA1 E3 连接酶在这些细胞功能中的精确作用仍不清楚。我们提出的数据表明,BRCA1 使 G2/M 细胞周期蛋白,细胞周期蛋白 B 和 Cdc25C 泛素化,导致它们通过 APC/C 独立的机制加速降解。BRCA1 依赖性细胞周期蛋白 B 和 Cdc25C 的降解可被蛋白酶体抑制剂逆转,并在 DNA 损伤后增强,这可能代表一种防止细胞周期蛋白 B 和 Cdc25C 积累的可能机制,而细胞周期蛋白 B 和 Cdc25C 的积累是有丝分裂进入的必要条件。我们的数据为 BRCA1 E3 连接酶活性如何调节 G2/M 细胞周期检查点提供了机制见解,从而有助于维持基因组稳定性。